Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00165737 · ClinicalTrials.gov registry record · Phase 3
Donepezil Hydrochloride (E2020) in Dementia Associated With Cerebrovascular Disease
A Phase 3 study, sponsored by Eisai.
- Completed
- Registry status
- Phase 3
- Development phase
- 974
- Enrollment target
NCT00165737 is a Phase 3 study that has completed, run by Eisai. The registered enrollment target is 974 participants.
The verdict
NCT00165737, a Phase 3 study, has completed, sponsored by Eisai.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 974 participants
- Enrollment target
Study Summary
Twenty-four week, prospective, randomized, double-blind, placebo-controlled, parallel-group study.
Interventions
- DRUG Donepezil Hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 974 participants |
| Start Date | 2003-03 |
| Est. Completion | 2006-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00165737
The ClinicalTrials.gov registry entry for NCT00165737 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 974 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eisai, which has 287 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Donepezil Hydrochloride is the first listed.
NCT00165737 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00165737 about?
NCT00165737 is a clinical study titled "Donepezil Hydrochloride (E2020) in Dementia Associated With Cerebrovascular Disease". Twenty-four week, prospective, randomized, double-blind, placebo-controlled, parallel-group study.
What is the current status of trial NCT00165737?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 974 participants. The study started on 2003-03. Estimated completion is 2006-06.
What interventions are being tested in trial NCT00165737?
The interventions under investigation include: Donepezil Hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00165737?
This trial is sponsored by Eisai, which has 287 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.